Autoimmune lymphoproliferative syndrome (ALPS) is a congenital disorder that results in an apoptosis impairment of lymphocytes, leading to chronic lymphoproliferation and autoimmunity, mainly autoimmune cytopenias. FAS gene defects are often responsible for the disease, the phenotype of which can vary from asymptomatic/mild forms to severe disease. More rarely, defects are associated to other genes involved in apoptosis pathway, such as CASP10. Few data are available on CASP10-mutated patients. To date, two CASP10 mutations have been recognized as pathogenic (I406L and L258F) and others have been reported with controversial result on their pathogenicity (V410l, Y446C) or are known to be polymorphic variants (L522l). In this study, we evaluated apoptosis function in patients with an ALPS/ALPS-like phenotype carrying CASP10 variants. Molecular findings were obtained by next generation sequencing analysis of genes involved in immune dysregulation syndromes. Functional studies were performed after inducing apoptosis by FAS-ligand/TRIAL stimulation and analysing cell death and the function of CASP10, CASP8 and PARP proteins. We identified 6 patients with an ALPS (n = 2) or ALPS-like (n = 4) phenotype, carrying I406L (n = 1),V410l (n = 2),Y446C (n = 1) heterozygous CASP10 variants or the L522l polymorphisms (n = 2) associated with another polymorphic homozygote variant on CASP8 or a compound heterozygous mutation on TNFRSF13C. Apoptosis was impaired in all patients showing that such variants may play a role in the development of clinical phenotype.

Conflict of interest

The authors declare no financial disclosures.

References

Campagnoli, M.F., Garbarini, L., Quarello, P., Garelli, E., Carando, A., Baravalle, V., Doria, A., Biava, A., Chiocchetti, A., Rosolen, A., Dufour, C., Dianzani, U. & Ramenghi, U. (2006) The broad spectrum of autoimmune lymphoproliferative disease: molecular bases, clinical features and long-term follow-up in 31 patients. Haematologica, 91, 538–541.
CAS PubMed Web of Science® Google Scholar
Cerutti, E., Campagnoli, M.F., Ferretti, M., Garelli, E., Crescenzio, N., Rosolen, A., Chiocchetti, A., Lenardo, M.J., Ramenghi, U. & Dianzani, U. (2007) Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome. BMC Immunology, 8, 28.
10.1186/1471-2172-8-28
CAS PubMed Web of Science® Google Scholar
Del-Rey, M., Ruiz-Contreras, J. & Allende, L.M. (2006) A homozygous fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome. Blood, 108, 1306–1312.
10.1182/blood-2006-04-015776
CAS PubMed Web of Science® Google Scholar
Dianzani, U., Bragardo, M., DiFranco, D., Alliaudi, C., Scagni, P., Buonfiglio, D., Redoglia, V., Bonissoni, S., Correra, A., Dianzani, I. & Ramenghi, U. (1997) Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation. Blood, 15, 2871–2879.
10.1182/blood.V89.8.2871
Web of Science® Google Scholar
Fischer, U., Stroh, C. & Schulze-Osthoff, K. (2006) Unique and overlapping substrate specificities of caspase-8 and caspase-10. Oncogene, 25, 152–159.
10.1038/sj.onc.1209015
CAS PubMed Web of Science® Google Scholar
Grønbaek, K., Dalby, T., Zeuthen, J., Ralfkiaer, E. & Guidberg, P. (2000) The V410I (G1228A) variant of the caspase-10 gene is a common polymorphism of the Danish population. Blood, 95, 2184–218.
10.1182/blood.V95.6.2184.2184
CAS PubMed Web of Science® Google Scholar
Holzelova, E., Vonarbourg, C., Stolzenberg, M.C., Arkwright, P.D., Selz, F., Prieur, A.M., Blanche, S., Bartunkova, J., Vilmer, E., Fischer, A., Le Deist, F. & Rieux-Laucat, F. (2004) Autoimmune lymphoproliferative syndrome with somatic Fas mutations. The new England Journal of Medecine, 351, 1409–1418.
10.1056/NEJMoa040036
CAS PubMed Web of Science® Google Scholar
Hu, Z., Li, C., Chen, K., Wang, L.E., Sturgis, E.M., Spitz, M.R. & Wei, Q. (2008) Single nucleotide polymorphisms in selected apoptotic genes and BPDE-induced apoptotic capacity in apparently normal primary lymphocytes: a genotype-phenotype correlation analysis. Journal of Cancer Epidemiology, 10, 147905.
Google Scholar
Hull, K.M., Drewe, E., Aksentijevich, I., Singh, H.K., Wong, K., McDermott, E.M., Dean, J., Powell, R.J. & Kastner, D.L. (2002) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine, 81, 349–368.
10.1097/00005792-200209000-00002
CAS PubMed Web of Science® Google Scholar
Ladogana, S., Maruzzi, M., Samperi, P., Condorelli, A., Casale, M., Giordano, P., Notarangelo, L.D., Farruggia, P., Giona, F., Nocerino, A., Fasoli, S., Casciana, M.L., Miano, M., Tucci, F., Casini, T., Saracco, P., Barcellini, W., Zanella, A., Perrotta, S. & Russo, G. (2018) AIHA Committee of the Associazione Italiana di Ematologia ed Oncologia Pediatrica. Second-line therapy in paediatric warm autoimmune haemolytic anaemia. Guidelines from the Associazione Italiana Onco-Ematologia Pediatrica (AIEOP). Blood Transfusion, 16, 352–357.
PubMed Web of Science® Google Scholar
Martínez-Feito, A., Melero, J., Mora-Díaz, S., Rodríguez-Vigil, C., Elduayen, R., González-Granado, L.I., Pérez-Méndez, D., Sánchez-Zapardiel, E., Ruiz-García, R., Menchén, M., Díaz-Madroñero, J., Paz-Artal, E., Del Orbe-Barreto, R., Riñón, M. & Allende, L.M. (2016) Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation. Immunobiology, 221, 40–47.
10.1016/j.imbio.2015.08.004
CAS PubMed Web of Science® Google Scholar
Miano, M. (2016) How I manage Evans syndrome and AIHA cases in children. British Journal of Haematology, 172, 524–534.
10.1111/bjh.13866
PubMed Web of Science® Google Scholar
Miano, M., Poggi, V., Banov, L., Fioredda, F., Micalizzi, C., Svahn, J., Montobbio, G., Gallicola, F., Molinari, A.C., Parasole, R., Petruzziello, F., Fischer, A., Calvillo, M. & Dufour, C. (2014a) Sirolimus as maintenance treatment in an infant with life-threatening multiresistant pure red cell anemia/autoimmune hemolytic anemia. Journal of Pediatric Hematology/Oncology, 36, e145–e148.
10.1097/MPH.0b013e31828d9928
PubMed Web of Science® Google Scholar
Miano, M., Calvillo, M., Palmisani, E., Fioredda, F., Micalizzi, C., Svahn, J., Banov, L., Russo, G., Lanza, T. & Dufour, C. (2014b) Sirolimus for the treatment of multi-resistant autoimmune haemolytic anaemia in children. British Journal of Haematology, 167, 571–574.
10.1111/bjh.13010
CAS PubMed Web of Science® Google Scholar
Miano, M., Scalzone, M., Perri, K., Palmisani, E., Caviglia, I., Micalizzi, C., Svahn, J., Calvillo, M., Banov, L., Terranova, P., Lanza, T., Dufour, C. & Fioredda, F. (2015) Mycophenolate mofetil and sirolimus as second or further line treatment in children with chronic refractory primary or secondary autoimmune cytopenias: a single centre experience. British Journal of Haematology, 171, 247–253.
10.1111/bjh.13533
CAS PubMed Web of Science® Google Scholar
Miano, M., Ramenghi, U., Russo, G., Rubert, L., Barone, A., Tucci, F., Farruggia, P., Petrone, A., Mondino, A., Lo, Valvo L., Crescenzio, N., Bellia, F., Olivieri, I., Palmisani, E., Caviglia, I., Dufour, C. & Fioredda, F. (2016) Mycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology/oncology. British Journal of Haematology, 175, 490–495.
10.1111/bjh.14261
CAS PubMed Web of Science® Google Scholar
Miano, M., Rotulo, G.A., Palmisani, E., Giaimo, M., Fioredda, F., Pierri, F., Pezzulla, A., Licciardello, M., Terranova, P., Lanza, T., Cappelli, E., Maggiore, R., Calvillo, M., Micalizzi, C., Russo, G. & Dufour, C. (2018) Sirolimus as a rescue therapy in children with immune thrombocytopenia refractory to mycophenolate mofetil. American Journal of Hematology., 93, e175–e177.
10.1002/ajh.25119
PubMed Web of Science® Google Scholar
Neven, B., Magerus-Chatinet, A., Florkin, B. & Rieux-Laucat, F. (2011) A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood, 118, 4798–4807.
10.1182/blood-2011-04-347641
CAS PubMed Web of Science® Google Scholar
Oliveira, J.B., Bleesing, J.J. & Rao, V.K. (2010) Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International workshop. Blood, 116, e35–e40.
10.1182/blood-2010-04-280347
CAS PubMed Web of Science® Google Scholar
Palmisani, E., Miano, M., Micalizzi, C., Calvillo, M., Pierri, F., Terranova, P., Lanza, T., Lanciotti, M., Riccardi, F., Todiere, A., Zanardi, S., Caviglia, I., Dufour, C. & Fioredda, F. (2019) Clinical features and therapeutic challenges of cytopenias belonging to ALPS and ALPS-related (ARS) phenotype. British Journal of Haematology, 184, 861–864.
10.1111/bjh.15178
PubMed Web of Science® Google Scholar
Ramenghi, U., Bonissoni, S., Migliaretti, G., DeFranco, S., Bottarel, F., Gambaruto, C., DiFranco, D., Priori, R., Conti, F., Dianzani, I., Valesini, G., Merletti, F. & Dianzani, U. (2000) Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer. Blood, 95, 3176–3182.
10.1182/blood.V95.10.3176
CAS PubMed Web of Science® Google Scholar
Rao, V.K., Price, S., Similuk, M., Niemela, J., Milner, J.D. & Rosenzweig, S. (2016) Clinical spectrum of Autoimmune Lymphoproliferative Syndrome associated with Caspase 10 mutations (ALPS-CASP10). Blood, 128, 1335.
10.1182/blood.V128.22.1335.1335
Web of Science® Google Scholar
Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I.A., Debatin, K.M., Fischer, A. & De Villartay, J.P. (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science, 268, 1347–1349.
10.1126/science.7539157
CAS PubMed Web of Science® Google Scholar
Tripodi, S.I., Mazza, C., Moratto, D., Ramenghi, U., Caorsi, R., Gattorno, M. & Badolato, R. (2016) Atypical presentation of autoimmune lymphoproliferative syndrome due to CASP10 mutation. Immunology Letters, 177, 22–24.
10.1016/j.imlet.2016.07.001
CAS PubMed Web of Science® Google Scholar
Wang, J., Zheng, L. & Lenardo, M.J. (1999) Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell, 98, 47–58.
10.1016/S0092-8674(00)80605-4
CAS PubMed Web of Science® Google Scholar
Zhu, S., Hsu, A.P., Vacek, M.M., Zheng, L., Schäffer, A.A., Dale, J.K., Davis, J., Fischer, R.E., Straus, S.E., Boruchov, D., Saulsbury, F.T., Lenardo, M.J. & Puck, J.M. (2006) Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome. Human Genetics, 119, 284–294.
10.1007/s00439-006-0138-9
CAS PubMed Web of Science® Google Scholar
Zhu, S., Jin, J., Gokhale, S., Lu, A.M., Shan, H., Feng, J. & Xie, P. (2018) Genetic alterations of TRAF proteins in human cancers. Frontiers in Immunology, 20, 9–2111.
Google Scholar

Citing Literature

Volume187, Issue4

November 2019

Pages 502-508

FAS-mediated apoptosis impairment in patients with ALPS/ALPS-like phenotype carrying variants on CASP10 gene

Summary

Conflict of interest

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

FAS-mediated apoptosis impairment in patients with ALPS/ALPS-like phenotype carrying variants on CASP10 gene

Summary

Conflict of interest

References

Citing Literature

References

Related

Information